Dispute mounts over Sanofi-Synthelabo's partnership with Zuellig

President Christian Stoeckling at Zuellig Pharma Korea said in its September 3 statement that Sanofi-Synthelabo Korea has decided to select Zuellig as one of the main outsourcing partners and from this September 1, Sanofi-Synthelabo Korea's whole drugs should be entirely supplied by Zuellig, claiming that the previous agreement provisions (Article 10: termination) executed between the foreign-i...